Hot Starts: Phase I Clinical Trials with Radiopharmaceutical

The growing adoption of Digital Twin (DT) technologies in healthcare highlights the need to define how medical imaging tools (physical and digital phantoms, real and simulated CT studies, etc.) integrate with the virtual componen...

Rectal spacers are widely used in prostate stereotactic ablative radiotherapy (SAbR) to reduce rectal dose; however, their value as a practical, planning-oriented QA tool remains underdefined. Using real-world clinical trial data...

Total body irradiation (TBI) is a well-established conditioning regimen prior to hematopoietic stem cell transplant (HSCT) for treatment of leukemia cancers. This study reports on a Central-Asian national referral cancer centre’s...

Standard dose optimization fails in low-resource settings due to unique patient phenotypes, heterogeneous aging equipment, and absent validation pathways. This work presents a closed-loop digital twin ecosystem that autonomously...

Describe highlights of organizational changes that allowed for the ramp-up of the radiopharmaceutical trials program at the University of Miami Health System (UHealth)

To develop risk-stratification and prognosis-prediction models for limited-stage small cell lung cancer (LS-SCLC) patients, suggesting potential candidates that may benefit from the new treatment protocol using high-dose hyperfra...